5-HTP (Griffonia simplicifolia).
Direct serotonin precursor for mood and sleep Boosts serotonin levels. Your brain uses it to make the feel-good neurotransmitter directly.
Reviewed March 2026
- Category
- Amino acid
- Also filed under
- SerotoninSleepMood
What 5-HTP (Griffonia simplicifolia) is, and what it does.
- Does it work
- Strong evidence for sleep and mood. One of the better-researched natural serotonin boosters.
- How much to take
- 50-100mg for sleep. Up to 300mg for mood support. Start low. Your gut will thank you.
- Time to feel it
- Drowsiness often shows up within an hour or two of an evening dose. Mood changes, where they come, take a couple of weeks of steady use.
- The first dose
- Drowsiness kicks in within an hour. Sleep quality usually improves the first night.
- With regular use
- Sleep benefits stay consistent. Mood effects can vary. Some build tolerance after a few months.
- How well tolerated
- Not one to combine with SSRIs or MAOIs without a prescriber, since the serotonin effect stacks. Tell your surgeon before any procedure. Nausea is the usual side effect.
- How it feels
- Relaxed but not drugged. Like your brain finally stopped buzzing. Dreams get interesting.
- The overlooked benefit
- The raw material is a crop, so the batch certificate is what tells you the actual 5-HTP content. Seed strength shifts with the harvest, which is why testing matters here.
50 to 150mg a day is where 5-HTP (Griffonia simplicifolia) works.
Source: Turner 2006 + Jangid 2013 depression study
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
5-HTP (Griffonia simplicifolia) has emerging evidence. Based on 2+ studies.
- Improves sleep qualityMultiple RCTs show benefit
- Treats depressionSome positive trials, needs more research
- Helps with weight lossMay reduce appetite, inconsistent results
Questions people ask about 5-HTP (Griffonia simplicifolia).
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Aromatic L-amino acid decarboxylase converts 5-hydroxytryptophan to serotonin and it requires pyridoxal 5-phosphate as its cofactor. P5P is that cofactor already in its active form, needing no hepatic conversion. This is the single most direct enzymatic partner for 5-HTP and it is settled biochemistry rather than a trial finding.
Magnesium is a cofactor for the ATP-dependent steps that follow serotonin along the pathway to melatonin, and it is required broadly for kinase activity in monoamine signalling. The pairing appears in relaxation-positioned formulas. The mechanistic link is real; a combination outcome has not been measured here.
Theanine is a glutamate analogue that shifts cortical activity toward alpha rhythm, a different route from the monoamine pathway 5-HTP feeds. Formulas combine them for evening use on that complementary basis. Anything additive on alertness is worth stating plainly rather than assuming it is only beneficial.
Glycine acts at its own inhibitory receptor and at the NMDA receptor glycine site, unrelated to serotonin synthesis. It is paired with 5-HTP in evening formulas for that separate inhibitory action. The combination is formulation convention, not a tested pair.
GABA is the principal inhibitory neurotransmitter and is often stacked with 5-HTP in relaxation formulas. Oral GABA crosses the blood-brain barrier poorly, which is the standing caveat on the ingredient itself. Any additive calming effect from the pair should be anticipated rather than assumed absent.
Apigenin binds the benzodiazepine site of the GABA-A receptor at low affinity, a mechanism separate from serotonin synthesis. It appears with 5-HTP in evening blends. The effect size for apigenin alone in people is not well characterised.
Chamomile carries apigenin and related flavones and is a traditional evening preparation. It is combined with 5-HTP in that context. Additive effects on alertness are the reason to name the pairing rather than a reason to promote it.
Valerian constituents interact with GABAergic signalling, a pathway distinct from monoamine synthesis. Stacking it with 5-HTP compounds a sedative direction. This is flagged as an additive effect to be aware of, not as a recommendation.
Passiflora preparations are used traditionally for evening calm and are associated with GABAergic activity in preclinical work. Combined with 5-HTP the sedative direction adds. Name the additive effect explicitly.
Melissa officinalis is associated with GABA transaminase inhibition in preclinical work and is used in evening blends. Its route does not overlap with serotonin synthesis. The pairing is additive on the same behavioural direction from two different mechanisms.
Honokiol and magnolol are described as positive modulators at GABA-A receptors in preclinical models. Magnolia is combined with 5-HTP in evening formulas on that basis. The human evidence for the botanical alone is limited.
Caffeine antagonises adenosine receptors and pushes alertness in the opposite direction from an evening-positioned serotonin precursor. Taking them together works against the reason each is in the formula. This is a timing conflict worth stating, not a chemical incompatibility.
Tryptophan hydroxylase, the rate-limiting enzyme that makes 5-hydroxytryptophan from tryptophan, is an iron-dependent monooxygenase. Supplemental 5-HTP enters the pathway after that step, so it does not depend on iron status the way endogenous synthesis does. The relationship is upstream and explains where 5-HTP sits in the sequence.
Several serotonin receptor subtypes signal through phospholipase C and the phosphatidylinositol second messenger system, for which inositol is the substrate. That makes inositol a downstream signalling component rather than a synthesis partner. The link is mechanistic and has not been tested as a combination.
Docosahexaenoic acid is concentrated in neuronal membrane phospholipid, where membrane composition influences receptor conformation and signalling. That is an indirect and non-specific relationship to serotonin signalling. Read it as mechanistic context rather than clinical support for the pair.
Rhodiola constituents are described in preclinical work as affecting monoamine turnover, so combining it with a monoamine precursor stacks two inputs into the same neurotransmitter system. That is a reason to name the pairing rather than to assume it is neutral. Human evidence for the combination is absent.
Withania preparations are studied for effects on the hypothalamic-pituitary-adrenal axis, a separate system from monoamine synthesis. They appear together in evening and stress-positioned formulas. The rationale is complementary positioning, not a shared pathway.
Most of the body's serotonin is made in enterochromaffin cells of the gut, and gut microbial metabolites influence that production. Live cultures are combined with 5-HTP on this reasoning. The link between a specific strain and host serotonin output in people is not established.
Nothing specific on file for 5-HTP (Griffonia simplicifolia). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What 5-HTP (Griffonia simplicifolia) actually does.
Your body builds serotonin from tryptophan in two steps, and the first step is the bottleneck. 5-HTP is the molecule that sits between them, so taking it lets you join the pathway after that control point rather than before it.
The enzyme that turns 5-HTP into serotonin needs the active form of vitamin B6 as its helper, which is why your B6 status sits directly on this pathway.
Tryptophan has to queue with other large amino acids for the same doorway into the brain. 5-HTP does not use that queue, so a meal with protein in it does not hold it up the same way.
The converting enzyme also lives in tissues outside the brain, so a share of an oral dose gets turned into serotonin out in the body before it ever reaches the central nervous system.
Where 5-HTP (Griffonia simplicifolia) comes from.
The seeds of a West African vine happen to store a lot of this compound, so it is pulled out with water or alcohol rather than built from scratch. The liquid is concentrated until crystals form, and those crystals are washed and tested until the powder is 95 percent or more of the one compound. Since the raw material is a crop, the batch test is what tells you what you actually have.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Pods are collected from the West African climbing shrub and the seeds are separated and dried.
Milled seed is extracted with water or aqueous ethanol, in which 5-hydroxytryptophan is soluble.
The extract is filtered, concentrated and the 5-hydroxytryptophan is crystallised out and washed to remove co-extracted seed constituents.
The dried crystals are assayed, typically by HPLC, and released against a stated 5-hydroxytryptophan percentage together with a residual solvent specification.
The purified powder is blended with excipients and filled, sometimes with an enteric or sustained-release coating.
Getting 5-HTP (Griffonia simplicifolia) from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Plasma 5-hydroxytryptophan rose after oral spray administration of a Griffonia simplicifolia extract and the authors relate that absorption to reported satiety measures; a small single-arm report with a self-reported endpoint.Open-label trial. Rondanelli et al., 2012 (Eating and Weight Disorders). PMID 22142813 ↗
- A review of natural ingredient supplementation and inflammatory-homeostatic signalling that names Griffonia-derived material within a wider set; mechanism-level discussion, not a trial of the ingredient.Narrative review. Bordano et al., 2025 (Nutrients). PMID 40871615 ↗
These are the studies our verdict leans on, chosen from the 2 we read for 5-HTP (Griffonia simplicifolia). The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
